Bellevue Life Sciences Acquisition Statistics Share Statistics Bellevue Life Sciences Acquisition has n/a
shares outstanding. The number of shares has increased by -42.6%
in one year.
Shares Outstanding n/a Shares Change (YoY) -42.6% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 2.31M Failed to Deliver (FTD) Shares 165,330 FTD / Avg. Volume 1.08K%
Short Selling Information The latest short interest is 9.35K, so 0% of the outstanding
shares have been sold short.
Short Interest 9.35K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -21.43 and the forward
PE ratio is null.
Bellevue Life Sciences Acquisition's PEG ratio is
0.03.
PE Ratio -21.43 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio -7.97 P/FCF Ratio -23.62 PEG Ratio 0.03
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Bellevue Life Sciences Acquisition.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.07,
with a Debt / Equity ratio of -0.27.
Current Ratio 0.07 Quick Ratio 0.07 Debt / Equity -0.27 Debt / EBITDA -0.5 Debt / FCF -0.81 Interest Coverage 81.96
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee n/a Employee Count undefined Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -296K Effective Tax Rate 14%
Stock Price Statistics The stock price has increased by -72.49% in the
last 52 weeks. The beta is 0.53, so Bellevue Life Sciences Acquisition's
price volatility has been higher than the market average.
Beta 0.53 52-Week Price Change -72.49% 50-Day Moving Average 10.9 200-Day Moving Average 10.89 Relative Strength Index (RSI) 13 Average Volume (20 Days) 15,258
Income Statement
Revenue n/a Gross Profit n/a Operating Income -3.52M Net Income -2.41M EBITDA -3.52M EBIT n/a Earnings Per Share (EPS) -0.54
Full Income Statement Balance Sheet The company has 66.14K in cash and 1.76M in
debt, giving a net cash position of -1.7M.
Cash & Cash Equivalents 66.14K Total Debt 1.76M Net Cash -1.7M Retained Earnings -8.33M Total Assets 2.3M Working Capital -6.26M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -2.19M
and capital expenditures 0, giving a free cash flow of -2.19M.
Operating Cash Flow -2.19M Capital Expenditures n/a Free Cash Flow -2.19M FCF Per Share -0.49
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
